Lead failure in transvenous implantable cardioverter defibrillator: a new opportunity for an effective management

por Pignalberi, Carlo, Colivicchi, Furio
Publicado 2018

Spotlight on Italian Association of Hospital Cardiologists (ANMCO) activity in the 2–year period 2021–2023

por Di Fusco, Stefania Angela, Colivicchi, Furio
Publicado 2023

Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials

por Colivicchi, Furio, Sternhufvud, Catarina, Gandhi, Sanjay K
Publicado 2015

Electrocardiographic characteristics, anthropometric features, and cardiovascular risk factors in a large cohort of adolescents

por Santini, Massimo, Di Fusco, Stefania Angela, Colivicchi, Furio, Gargaro, Alessio
Publicado 2018

The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure

por Colivicchi, Furio, Di Fusco, Stefania Angela, Magnanti, Massimo, Cipriani, Manlio, Imperoli, Giuseppe
Publicado 2020

Reply to Kielb et al. Untapped Potential for Female Patients? Comment on “Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176”

por Lucà, Fabiana, Colivicchi, Furio, Rossini, Roberta, Riccio, Carmine, Gelsomino, Sandro, Gulizia, Michele Massimo
Publicado 2022

Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes

por Gronda, Edoardo G., Vanoli, Emilio, Iacoviello, Massimo, Urbinati, Stefano, Caldarola, Pasquale, Colivicchi, Furio, Gabrielli, Domenico
Publicado 2022

Lipoprotein (a), Inflammation, and Atherosclerosis

por Di Fusco, Stefania Angela, Maggioni, Aldo Pietro, Scicchitano, Pietro, Zuin, Marco, D’Elia, Emilia, Colivicchi, Furio
Publicado 2023

ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with an...

por Gronda, Edoardo, Napoli, Claudio, Iacoviello, Massimo, Urbinati, Stefano, Caldarola, Pasquale, Mannucci, Edoardo, Colivicchi, Furio, Gabrielli, Domenico
Publicado 2021

Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care

por Colivicchi, Furio, Gulizia, Michele Massimo, Franzini, Laura, Imperoli, Giuseppe, Castello, Lorenzo, Aiello, Alessandro, Ripellino, Claudio, Cataldo, Nazarena
Publicado 2016

Mapping of ventricular tachycardia in patients with ischemic cardiomyopathy: Current approaches and future perspectives

por Pandozi, Claudio, Lavalle, Carlo, Russo, Maurizio, Galeazzi, Marco, Ficili, Sabina, Malacrida, Maurizio, Centurion Aznaran, Carlos, Colivicchi, Furio
Publicado 2019

ANMCO Position Paper: diagnostic–therapeutic pathway in patients with hypercholesterolaemia and statin intolerance

por Gulizia, Michele Massimo, Colivicchi, Furio, Arca, Marcello, Abrignani, Maurizio Giuseppe, Perna, Gian Piero, Mureddu, Gian Francesco, Nardi, Federico, Riccio, Carmine
Publicado 2017

ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes

por Colivicchi, Furio, Gulizia, Michele Massimo, Arca, Marcello, Abrignani, Maurizio Giuseppe, Perna, Gian Piero, Mureddu, Gian Francesco, Nardi, Federico, Riccio, Carmine
Publicado 2017

Italian Association of Hospital Cardiologists practical guidance for sodium–glucose cotransporter 2 inhibitors use in patients with heart failure

por Di Fusco, Stefania Angela, Spinelli, Antonella, Aquilani, Stefano, Borrelli, Nunzia, Iannopollo, Gianmarco, Gulizia, Michele Massimo, Gabrielli, Domenico, Oliva, Fabrizio, Colivicchi, Furio
Publicado 2023

Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologis...

por De Luca, Leonardo, Colivicchi, Furio, Gulizia, Michele Massimo, Pugliese, Francesco Rocco, Ruggieri, Maria Pia, Musumeci, Giuseppe, Cibinel, Gian Alfonso, Romeo, Francesco
Publicado 2017

Impact of Working from Home on Cardiovascular Health: An Emerging Issue with the COVID-19 Pandemic

por Di Fusco, Stefania Angela, Spinelli, Antonella, Castello, Lorenzo, Mocini, Edoardo, Gulizia, Michele Massimo, Oliva, Fabrizio, Gabrielli, Domenico, Imperoli, Giuseppe, Colivicchi, Furio
Publicado 2021

Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey

por Camilli, Massimiliano, Bisceglia, Irma, Canale, Maria Laura, Turazza, Fabio Maria, De Luca, Leonardo, Gabrielli, Domenico, Gulizia, Michele Massimo, Oliva, Fabrizio, Colivicchi, Furio
Publicado 2023

How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post‐MI Study

por De Luca, Leonardo, Colivicchi, Furio, Meessen, Jennifer, Uguccioni, Massimo, Piscione, Federico, Bernabò, Paola, Lardieri, Gerardina, Granatelli, Antonino, Gabrielli, Domenico, Gulizia, Michele M.
Publicado 2019

Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries

por Colivicchi, Furio, Massimo Gulizia, Michele, Arca, Marcello, Luigi Temporelli, Pier, Gonzini, Lucio, Venturelli, Vanessa, Morici, Nuccia, Indolfi, Ciro, Gabrielli, Domenico, De Luca, Leonardo
Publicado 2020

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events

por De Luca, Leonardo, Bellettini, Elisa, Di Maio, Dario, Natale, Enrico, Putini, Rita Lucia, Anticoli, Sabrina, Colivicchi, Furio, Calabrò, Paolo, Musumeci, Francesco, Gabrielli, Domenico
Publicado 2021